Keyphrases
Pregnant Women
100%
Short-term Outcomes
100%
BNT162b2
100%
Coronavirus Disease 2019 Vaccine
100%
Second Dose
58%
Non-pregnant Women
50%
COVID-19
41%
Immunoglobulin G
41%
First Dose
41%
Third Trimester
25%
Vaccination
25%
G-levels
25%
Digital Survey
25%
Age-matched
16%
Two-dose
16%
Dosing Regimen
16%
Obstetric Outcomes
16%
Uterine Contraction
16%
BNT162b2 Vaccine
16%
Local Pain
16%
Vaccine Dose
16%
No Significant Difference
8%
Blood Test
8%
Neonatal Intensive Care Unit
8%
Pregnancy Outcome
8%
Headache
8%
Rash
8%
Medical History
8%
Obstetric Complications
8%
Fever
8%
Gestational Age at Delivery
8%
Neonatal Outcome
8%
Vaginal Bleeding
8%
Neonatal Death
8%
Serum Samples
8%
Myalgia
8%
Due Date
8%
Preterm Birth
8%
Immunogenicity
8%
Humoral Immune Response
8%
Serology
8%
Safety Concerns
8%
Respiratory Support
8%
Prelabor Rupture of Membranes
8%
Delivery Outcomes
8%
Arthralgia
8%
Pregnancy Stages
8%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
8%
Pregnant Population
8%
Paresthesia
8%
Fetal Death
8%
Age of Infection
8%
Pregnancy Trimester
8%
Pfizer-BioNTech BNT162b2
8%
Signal-to-cutoff Ratio
8%
Local Swelling
8%
Axillary Lymphadenopathy
8%
Severe Fatigue
8%
Reactogenicity
8%
Vaccination Dose
8%
Adverse Effect Profile
8%
Period Batch Control
8%
Low Serum
8%
Second Trimester of Pregnancy
8%
Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immunoglobulin G
83%
Third Trimester Pregnancy
50%
Side Effect
33%
Obstetrics
33%
Drug Dose Regimen
33%
Uterine Contraction
33%
Pregnancy
16%
Drug Therapy
16%
Headache
16%
Infection
16%
Medical History
16%
Obstetric Complication
16%
Second Trimester Pregnancy
16%
Gestational Age
16%
Adverse Event
16%
First Trimester Pregnancy
16%
Vagina Bleeding
16%
Neonatal Intensive Care Unit
16%
Exanthem
16%
Rupture of Membranes
16%
Newborn Death
16%
Dose Response
16%
Myalgia
16%
Premature Labor
16%
Assisted Ventilation
16%
Arthralgia
16%
Fetus Death
16%
Paresthesia
16%
Axillary Lymphadenopathy
16%
Reactogenicity
16%
Immunogenicity
16%
Humoral Immunity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coronavirinae
100%
SARS Coronavirus
100%
Disease
100%
Immunoglobulin G
83%
Vaccination Policy
66%
Side Effect
33%
Immunogenicity
16%
Headache
16%
Infection
16%
Adverse Event
16%
Rash
16%
Medical History
16%
Myalgia
16%
Premature Labor
16%
Fetus Death
16%
Vagina Bleeding
16%
Newborn Death
16%
Lymphadenopathy
16%
Paresthesia
16%
Arthralgia
16%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Coronavirinae
100%
SARS Coronavirus
100%
Immunoglobulin G
83%
Third Trimester Pregnancy
50%
Uterus Contraction
33%
Drug Dose Regimen
33%
Pregnancy
16%
First Trimester Pregnancy
16%
Second Trimester Pregnancy
16%
Serology
16%
Humoral Immunity
16%
Immunogenicity
16%
Immunology and Microbiology
COVID-19
100%
Vaccine Efficacy
100%
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Immunoglobulin G
50%
Vaccination Policy
40%
Third Trimester Pregnancy
30%
Uterus Contraction
20%
Drug Dose Regimen
20%
Humoral Immunity
10%
Immunogenicity
10%
Pregnancy
10%
Second Trimester Pregnancy
10%
First Trimester Pregnancy
10%
Lymphadenopathy
10%
Serology
10%